Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors.
Langenberg MHG, Witteveen PO, Roodhart J, Lolkema MP, Verheul HMW, Mergui-Roelvink M, Brendel E, Krätzschmar J, Loembé B, Nol-Boekel A, Christensen O, Schellens JHM, Voest EE. Langenberg MHG, et al. Among authors: voest ee. Ann Oncol. 2011 Nov;22(11):2508-2515. doi: 10.1093/annonc/mdq767. Epub 2011 Mar 4. Ann Oncol. 2011. PMID: 21378200 Free article. Clinical Trial.
Clinical research on antiangiogenic therapy.
Kuiper RA, Schellens JH, Blijham GH, Beijnen JH, Voest EE. Kuiper RA, et al. Among authors: voest ee. Pharmacol Res. 1998 Jan;37(1):1-16. doi: 10.1006/phrs.1997.0268. Pharmacol Res. 1998. PMID: 9503474 Review.
[The clinical perspective of angiogenesis inhibitors].
Radema SA, Witteveen PO, Gebbink MB, Voest EE. Radema SA, et al. Among authors: voest ee. Ned Tijdschr Geneeskd. 2003 Aug 30;147(35):1675-80. Ned Tijdschr Geneeskd. 2003. PMID: 14513538 Review. Dutch.
Are tumours angiogenesis-dependent?
Verheul HM, Voest EE, Schlingemann RO. Verheul HM, et al. Among authors: voest ee. J Pathol. 2004 Jan;202(1):5-13. doi: 10.1002/path.1473. J Pathol. 2004. PMID: 14694516 Review.
Fibronectin is a hypoxia-independent target of the tumor suppressor VHL.
Bluyssen HA, Lolkema MP, van Beest M, Boone M, Snijckers CM, Los M, Gebbink MF, Braam B, Holstege FC, Giles RH, Voest EE. Bluyssen HA, et al. Among authors: voest ee. FEBS Lett. 2004 Jan 2;556(1-3):137-42. doi: 10.1016/s0014-5793(03)01392-9. FEBS Lett. 2004. PMID: 14706840 Free article.
364 results